Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Association of Hormonal Contraception With Depression
Charlotte Wessel Skovlund, Lina Steinrud Mørch,
Lars Vedel Kessing
,
Øjvind Lidegaard
Department of Public Health
Department of Clinical Medicine
207
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Association of Hormonal Contraception With Depression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hormonal Contraception
100%
Antidepressants
70%
Depression Diagnosis
50%
Rate Ratio
50%
First Use
40%
Combined Oral Contraceptives
30%
Psychiatric Hospital
20%
Progestin-only pill
20%
First Diagnosis
20%
Denmark
20%
Antidepressant Use
10%
Prospective Cohort Study
10%
Adolescent Age
10%
Data Combination
10%
Prescription Register
10%
Time-dependent Covariates
10%
Clinical Evidence
10%
Lower Estimate
10%
Research Register
10%
Potential Adverse Effects
10%
Ratio Estimate
10%
Contraceptive Use
10%
Venous Thrombosis
10%
Infertility Treatment
10%
Relative Risk
10%
Psychiatric Diagnosis
10%
Incidence Rate
10%
Mood Disturbance
10%
Increasing Age
10%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
10%
Vaginal Ring
10%
Medicine and Dentistry
Hormonal Contraception
100%
Antidepressant
100%
Oral Contraceptive Agent
37%
Adolescence
37%
Diagnosis of Depression
37%
Contraceptive Agent
25%
Gestagen
25%
Mental Hospital
25%
Mood Disorder
12%
Levonorgestrel
12%
Psychiatric Diagnosis
12%
Prospective Cohort Study
12%
Adverse Event
12%
Vagina Ring
12%
Contraceptive Behavior
12%
Malignant Neoplasm
12%
Phlebothrombosis
12%
Neuroscience
Antidepressant
100%
Hormonal Contraception
100%
Adverse Effect
12%
Levonorgestrel
12%
Mood Disorder
12%
Progestin
12%
Vaginal Ring
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Oral Contraceptive Agent
37%
Progestin
25%
Contraceptive Agent
25%
Malignant Neoplasm
12%
Levonorgestrel
12%
Prospective Cohort Study
12%
Adverse Event
12%
Mood Disorder
12%
Vein Thrombosis
12%